Please login to the form below

Not currently logged in
Email:
Password:

Astellas poaches new oncology head from Takeda

Claire Thom is named senior VP of global oncology development

Astellas Claire ThomDr Claire Thom has left her role at Takeda to join rival Japanese pharma company Astellas as senior VP of global oncology development.

Dr Thom was most recently senior VP portfolio management, drug development management and strategic business operations at Millennium, the oncology-focused subsidiary of Takeda.

She will now lead Astellas' efforts in cancer, which include prostate cancer drug Xtandi (enzalutamide) and Tarveca (erlotinib) – a lung cancer drug co-marketed by Roche.

At Millennium Dr Thom will have worked on Velcade, a drug co-developed with Johnson & Johnson (J&J) that is used in blood cancer.

"We're thrilled that Claire is joining our experienced oncology team at Astellas," said Dr Sef Kurstjens, chief medical officer of Astellas.

“We believe that her unique background and varied experience, along with her approach to leadership and management will support our mission to become a global category leader in oncology."

Prior to joining Millennium, Dr Thom served for several years at Takeda itself, including holding responsibility for the oversight and implementation of the global therapeutic area strategies for the company's oncology, urology and gynaecology franchises.

14th August 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics